Xenetic Biosciences, Inc. Share Price
NASDAQ: XBIO$0.00
+0.00 (0.00%) Xenetic Biosciences, Inc. Stock Performance
Xenetic Biosciences, Inc. Share Price Chart
$0.00$0.00
L
H
Xenetic Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
Xenetic Biosciences, Inc. Annual Profit & Loss
All figures in USD
About Xenetic Biosciences, Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.
Xenetic Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.12 | $1.71 | -14.50% |
Oct 2026 | $2.25 | $2.00 | -10.31% |
Sep 2026 | $4.43 | $2.23 | -42.00% |
Aug 2026 | $2.75 | $3.85 | +45.64% |
Jul 2026 | $2.85 | $2.64 | -12.29% |
Jun 2026 | $3.14 | $3.01 | -3.83% |
May 2026 | $3.15 | $3.13 | +1.29% |
Apr 2026 | $2.98 | $3.09 | +13.19% |
Mar 2026 | $2.52 | $2.73 | +13.75% |
Feb 2026 | $2.25 | $2.40 | +5.73% |
Jan 2026 | $2.15 | $2.27 | +6.57% |
Dec 2025 | $2.50 | $2.13 | -21.11% |